Latest filing published 01 Apr 2022 for Zosano Pharma Corp, €760.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Donald J. Kellerman is a declared insider of Zosano Pharma Corp (senior executive), with filings sourced from SEC (Form 4). The record holds 6 filings, for trades running from 19 August 2016 to 31 March 2022.
In open-market terms, that means 1 purchase worth €19k on one side and 2 sales worth €1,894 on the other. On balance, insiders were net buyers of €17k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants. So far in 2022, the count stands at no purchases and 1 sale.
The record was last updated on 1 April 2022 with an open-market sale (€760) in Zosano Pharma Corp. The most recent open-market purchase was published on 22 August 2016, 3,714 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations